CrossRef enabled

PAC Archives

Archive →

Pure Appl. Chem., 2008, Vol. 80, No. 10, pp. 2195-2230

http://dx.doi.org/10.1351/pac200880102195

ORGANIC AND BIOMOLECULAR CHEMISTRY DIVISION
SUBCOMMITTEE ON BIOMOLECULAR CHEMISTRY

Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report)

M. Mosihuzzaman and M. Iqbal Choudhary

H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan

References

  • 1. British Medical Association. Complementary Medicine New Approaches to Good Practice, Oxford University Press, Oxford (1993).
  • 2. R. C. Kessler, R. B. Davis, D. A. Foster, M. I. Van Rompay, E. E. Walters, S. A. Wilkey, T. J. Kaptchuk, D. M. Eisenberg. Ann. Intern. Med. 135, 262 (2001).
  • 3. A. H. MacLennan, D. H. Wilson, A. W. Taylor. Prev. Med. 35, 166 (2002). (http://dx.doi.org/10.1006/pmed.2002.1057)
  • 4. C. M. Cassidy. J. Altern. Complement. Med. 4, 17 (1998). (http://dx.doi.org/10.1089/acm.1998.4.1-17)
  • 5. A. Bensoussan, S. P. Myers. Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia, Faculty of Health, University of Western Sydney, Macarthur (1996).
  • 6. TDR 2005. Operational Guidance: Information Needed to Support Clinical Trials of Herbal Products, UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) (2005).
  • 7. E. Ernst. Clin. Pharmacol. Ther. 70, 497 (2001). (http://dx.doi.org/10.1067/mcp.2001.120249)
  • 8. E. Ernst. J. Intern. Med. 252, 107 (2002). (http://dx.doi.org/10.1046/j.1365-2796.2002.00999.x)
  • 9. E. Ernst. Trends Pharmacol. Sci. 23, 136 (2002). (http://dx.doi.org/10.1016/S0165-6147(00)01972-6)
  • 10. P. A. G. M. De Smet, R. F. Chandler, P. P. H. But, K. Keller (Eds.). Adverse Effects of Herbal Drugs: Toxicological Outlook on the Quality Assurance of Herbal Medicines, pp. 1-72, Springer Verlag, Berlin (1992).
  • 11. "Quality of herbal remedies", in The Rules Governing Medicinal Products in the European Community, Office for Official Publications of the European Communities, Luxembourg, III, 31 (1989).
  • 12. T. Y. K. Chan, J. C. N. Chan, B. Tomlinson, J. A. J. H. Critchley. Lancet 342, 1532 (1993). (http://dx.doi.org/10.1016/S0140-6736(05)80091-1)
  • 13. S. Brown, R. Ede. Br. J. Hosp. Med. 53, 469 (1996).
  • 14. H. H. Schaumburg, A. Berger. J. Am. Med. Assoc. 268, 3430 (1992). (http://dx.doi.org/10.1001/jama.268.24.3430)
  • 15. E. O. Espinoza, M.-J. Mann, B. Bleasdell. N. Engl. J. Med. 333, 803 (1995). (http://dx.doi.org/10.1056/NEJM199509213331217)
  • 16. R. J. Ko. N. Engl. J. Med. 339, 847 (1998). (http://dx.doi.org/10.1056/NEJM199809173391214)
  • 17. G. M. Woolf, L. M. Petrovic, S. E. Rojter, S. Wainwright, F. G. Villamil, W. N. Katkov, P. Michieletti, I. R. Wanless, R. Stermitz, J. J. Beck, J. M. Vierling. Ann. Intern. Med. 121, 729 (1994).
  • 18. J.-L. Vanherweghem, C. Tielemans, D. Abramowicz, M. Depierreux, R. Vanhaelen-Fastre, R. Vanhaelen, M. Vanhaelen, M. Drawta, C. Richard, D. Vendervelde, D. Verbeelen, M. Jadoul. Lancet 341, 387 (1993). (http://dx.doi.org/10.1016/0140-6736(93)92984-2)
  • 19. T. Y. K. Chan, J. A. J. H. Critchley. Hum. Exp. Toxicol. 15, 5 (1996).
  • 20. T. J. Kaptchuk. Ann. Intern. Med. 122, 636 (1995).
  • 21. G. J. Park, S. P. Mann, M. C. Ngu. J. Gastroenterol. Hepatol. 16, 115 (2001). (http://dx.doi.org/10.1046/j.1440-1746.2001.02309.x)
  • 22. P. P. But, D. J. Atherton, M. H. Rustin, J. Brostoff. Lancet 341, 637 (1993). (http://dx.doi.org/10.1016/0140-6736(93)90404-5)
  • 23. M. Vanhaelen, R. Vanhaelen-Fastre, P. But, J.-L. Vanherweghem. Lancet 343, 174 (1994). (http://dx.doi.org/10.1016/S0140-6736(94)90964-4)
  • 24. M. Depierreux, B. Van Damme, K. V. Houte, J.-L. Vanherweghem. Am. J. Kidney Dis. 24, 172 (1994).
  • 25. J.-P. Cosyns, M. Jadoul, J.-P. Squifflet, J.-F. De Plaen, D. Ferluga, C. V. Y. de Strihou. Kidney Int. 45, 1680 (1994). (http://dx.doi.org/10.1038/ki.1994.220)
  • 26. P. A. G. M. De Smet, P. A. G. M. De Smet, K. Keller, R. Hansel, R. F. Chandler (Eds.). Adverse Effects of Herbal Drugs, Aristolochia Species, pp. 79-89, Springer Verlag, Berlin (1992).
  • 27. L. J. Vanherwegham. J. Altern. Complement. Med. 4, 9 (1998). (http://dx.doi.org/10.1089/acm.1998.4.1-9)
  • 28. J.-P. Cosyns, M. Jadoul, J.-P. Squifflet, P.-J. Van Cangh, C. V. Y. de Strihou. Lancet 344, 188 (1994). (http://dx.doi.org/10.1016/S0140-6736(94)92786-3)
  • 29. Therapeutic Goods Administration (TGA) (Australia). Chinese herbal medicines in Australia found to contain Aristolochia <http://www.tga.gov.au/> (2003).
  • 30. ICDRA. International Conference on Drug Regulatory Authorities, World Health Organization (1986).
  • 31. ICDRA. 6th International Conference on Drug Regulatory Authorities, World Health Organization (1991).
  • 32. ICDRA. 8th International Conference on Drug Regulatory Authorities, World Health Organization, Bahrain, 10-13 Nov. (1996).
  • 33. ICDRA. 9th International Conference on Drug Regulatory Authorities, World Health Organization, Berlin, 25-29 April (1999).
  • 34. G. Shia, B. Noller, G. Burford. "Safety issues and policies", in Traditional, Complementary and Alternative Medicine: Policy and Public Health Perspectives, G. Bodeker, G. Burford (Eds.), Chap. 4, pp. 83-98, Imperial College Press, London (2007).
  • 35. Therapeutic Goods Administration (TGA) (Australia). <http://www.tga.gov.au/cm/cm.htm> (2004).
  • 36. TDR. Operational Guidance: Information Needed to Support Clinical Trials of Herbal Products, UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) (2005).
  • 37. P. F. Ricci. Environmental and Health Risk Assessment and Management: Principles and Practices, Springer, Dordrecht (2006).
  • 38. Standards Association of Australia. Risk Management AS/NZS, p. 4360, Strathfield, NSW (1999).
  • 39. M. R. Sim, J. J. McNeil. Med. J. Aust. 170, 372 (1999).
  • 40. EnHealth. Environmental Health Risk Assessment: Guidelines for Assessing Human Health Risks from Environmental Hazards, p. 227, Department of Health and Aged Care and enHealth Council, Canberra (2002).
  • 41. USEPA. Guidelines for Ecological Risk Assessment, p. 188, U.S. Environmental Protection Agency, Washington, DC (1998).
  • 42. Aristotle. Organon, in Masterpieces of World Philosophy, N. Magill (Ed.), p. 137, George Allen & Unwin, London (1963).
  • 43. C. H. Hennekens, J. E. Buring. "Design strategies in epidemiologic research", in Epidemiology in Medicine, S. L. Mayrent (Ed.), p. 16, Lippincott Williams & Wilkins, Philadelphia (1987).
  • 44. S. Plantadosis. In Clinical TrialsA Methodologic Perspective, Plantadosis (Ed.), p. 9, Wiley-Interscience, New York (2005).
  • 45. R. H. Fletcher, S. W. Fletcher. N. Eng. J. Med. 301, 180 (1979).
  • 46. S. Plantadosis. In Clinical TrialsA Methodologic Perspective, Plantadosis (Ed.), p. 82, Wiley-Interscience, New York (2005).
  • 47. M. Pawa. In Complimentary Therapy and the Management of Diabetes and Vascular DiseaseA Matter of Balance, P. T. Dunning (Ed.), p. 17, John Wiley, Chichester (2006). (http://dx.doi.org/10.1002/9780470057438.ch2)
  • 48. O. Akerele. Herbalgram 28, 13 (1993).
  • 49. J. Benedum. In Phytopharmaka IV. Forschung und Klinische Anwendung, D. Loew, N. E. Rietbrock (Eds.), p. 3, Darmstadt, Steinkopff (1998).
  • 50. B. Patwardhan, D. Warude, P. Pushpangadan, N. Bhatt. Evidence-Based Complem. Altern. Med. 2, 465 (2005).
  • 51. WHO. Traditional Medicine Strategy 2002-2005. <www.who.int/medicines/library/trm/trm_stat_eng.pdfS> (2002).
  • 52. J. Gruenwald. Herbalgram 34, 61 (1995).
  • 53. L. Lee. J. Nurse-Midwifery 44, 253 (1999). (http://dx.doi.org/10.1016/S0091-2182(99)00042-7)
  • 54. J. S. Brown, S. A. Marcy. Res. Nurs. Health 14, 339 (1991). (http://dx.doi.org/10.1002/nur.4770140505)
  • 55. S. Bent, R. Ko. Am. J. Med. 116, 478 (2004). (http://dx.doi.org/10.1016/j.amjmed.2003.10.036)
  • 56. I. A. Khan. Life Sci. 78, 2033 (2006). (http://dx.doi.org/10.1016/j.lfs.2005.12.019)
  • 57. J. L. Nortier, M.-C. M. Martinez, H. H. Schmeiser, V. M. Arlt, C. A. Bieler, M. Petein, F. Depierreux, L. De Pauw, D. Abramowicz, P. Vereerstraeten, J. L. Vanherweghem. N. Engl. J. Medicine 342, 1686 (2000). (http://dx.doi.org/10.1056/NEJM200006083422301)
  • 58. H. L. Koh, S. O. Woo. Drug Safety 23, 351 (2000). (http://dx.doi.org/10.2165/00002018-200023050-00001)
  • 59. V. S. Srinivasan. Life Sci. 78, 2039 (2006). (http://dx.doi.org/10.1016/j.lfs.2005.12.014)
  • 60. G. Ulrich-Merzenich, H. Zeitler, D. Jobst, D. Panek, H. Vetter, H. Wagner. Phytomedicine 14, 70 (2007). (http://dx.doi.org/10.1016/j.phymed.2006.11.011)
  • 61. EMEA. Position paper on the risks associated with the use of herbal products containing Aristolochia species. EMEA/HMPWP/23/00 (2000).
  • 62. E. Ernst. Eur. J. Clin. Pharmacol. 56, 523 (2000). (http://dx.doi.org/10.1007/s002280000194)
  • 63. E. Ernst. J. Int. Med. 252, 107 (2002). (http://dx.doi.org/10.1046/j.1365-2796.2002.00999.x)
  • 64. L. C. Winslow, D. J. Kroll. Arch. Intern. Med. 158, 2192 (1998). (http://dx.doi.org/10.1001/archinte.158.20.2192)
  • 65. M. Rotblatt, I. Ziment. Evidence-Based Herbal Medicine, Hanley & Belfus, Philadelphia (2002).
  • 66. M. Blumenthal (Ed.). The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines, American Botanical Council, Austin, TX (1997).
  • 67. CDER/USFDA. Guidance for Industry, Botanical Drug Products, draft guidance, Center for Drug Evaluation and Research/U.S. Food and Drug Administration (2000).
  • 68. EMEA. Guideline on Specifications: Test Procedures and Acceptance Criteria for Herbal Drugs, Herbal Drug Preparations and Herbal Medicinal Products/Traditional Herbal Medicinal Products, European Medicines Agency, London, EMEA/CPMP/QWP/2820/00 Rev. 1 and (EMEA/CVMP/815/00), Rev. 1 (2006).
  • 69. The 2002 United States Pharmacopoeia and National Formulary, USP 25 NF 19/National Formulary 20, Rockville, MD, U.S. Pharmacopoeial Convention, Inc. (2002).
  • 70. Pharmacopoeia of the People's Republic of China, English ed., The Pharmacopoeia Commission of PRC, Beijing (2000).
  • 71. C. W. Huie. Anal. Bioanal. Chem. 373, 23 (2002). (http://dx.doi.org/10.1007/s00216-002-1265-3)
  • 72. V. Camel. Trends Anal. Chem. 19, 229 (2000). (http://dx.doi.org/10.1016/S0165-9936(99)00185-5)
  • 73. B. Kaufmann, S. Rudaz, S. Cherkaoui, J.-L. Veuthey, P. Christen. Phytochem. Anal. 18, 70 (2007). (http://dx.doi.org/10.1002/pca.954)
  • 74. A. Brachet, S. Rudaz, L. Mateus, P. Christen, J.-L. Veuthey. J. Separation Sci. 24, 865 (2001). (http://dx.doi.org/10.1002/1615-9314(20011101)24:10/11<865::AID-JSSC865>3.0.CO;2-U)
  • 75. B. Kaufmann, P. Christen, J.-L. Veuthey. Chromatographia 54, 394 (2001). (http://dx.doi.org/10.1007/BF02492690)
  • 76. V. Fernandez-Perez, M. M. Jimenez-Carmona, M. D. L. De Castro. Analyst 125, 481 (2000). (http://dx.doi.org/10.1039/a907244f)
  • 77. M. M. Jimenez-Carmona, J. L. Ubera, M. D. L. de Castro. J. Chromatogr., A 855, 625 (1999). (http://dx.doi.org/10.1016/S0021-9673(99)00703-7)
  • 78. A. Basile, M. M. Jimenez-Carmona, A. A. Clifford. J. Agric. Food Chem. 46, 5205 (1998). (http://dx.doi.org/10.1021/jf980437e)
  • 79. V. B. Guliyeva, M. Gulb, A. Yildirima. J. Chromatogr., B 812, 291 (2004).
  • 80. K. Hostettmann, J. L. Wolfender. "Rapid determination on plant glycosides by LC/MS and LC/NMR", in Advances in Plant Glycosides, Chemistry and Biology, C. R. Yang, O. E. Tanaka (Eds.), p. 233, Elsevier, Amsterdam (1999). (http://dx.doi.org/10.1016/S0928-3420(99)80032-9)
  • 81. P. S. Belton, I. J. Colquhoun, E. K. Kemsley, I. Delgadillo, P. Roma, M. J. Dennis, M. Sharman, E. Holmes, J. K. Nicholson, M. Spraul. Food Chem. 61, 207 (1998). (http://dx.doi.org/10.1016/S0308-8146(97)00103-9)
  • 82. M. Frederich, Y. H. Choi, L. Angenot, G. Harnischfeger, A. W. M. Lefeber, R. Verpoorte. Phytochemistry 65, 1993 (2004). (http://dx.doi.org/10.1016/j.phytochem.2004.06.015)
  • 83. H. K. Choi, Y. H. Choi, M. Verberne, A. W. M. Lefeber, C. Erkelens, R. Verpoorte. Phytochemistry 65, 857 (2004). (http://dx.doi.org/10.1016/j.phytochem.2004.01.019)
  • 84. P. J. Hylands, J. K. Nicholson, E. Holmes, M. J. Dunn. U.S. patent 6806090 (2004).
  • 85. P. Mionodies, P. Pommier, E. Moulene, K. Retornaz, N. Prost, L. Dehoro. Arch. Pediatrics 10, 619 (2003). (http://dx.doi.org/10.1016/S0929-693X(03)00274-4)
  • 86. Anon. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine, p. 4, World Health Organization, Geneva (2000).
  • 87. A. T. Elamthuruthya, C. R. Shah, T. A. Khan, P. A. Tatke, S. Y. Gabhe. J. Pharm. Biomed Anal. 37, 937 (2005). (http://dx.doi.org/10.1016/j.jpba.2004.11.044)
  • 88. G. Biringanine, M.-T. Chirelli, M. Faes, P. Duez. Talanta 69, 418 (2006). (http://dx.doi.org/10.1016/j.talanta.2005.10.007)
  • 89. E. A. Abouarshed, I. A. Khan. J. Pharm. Sci. 90, 817 (2001). (http://dx.doi.org/10.1002/jps.1035)
  • 90. H. Elsohly, E. M. Croom, M. A. Elsohly. Pharm. Res. 4, 258 (1987). (http://dx.doi.org/10.1023/A:1016472531527)
  • 91. H. Ganzora, E. Bedin, I. A. Khan. J. Pharm. Sci. 90, 1752 (2001). (http://dx.doi.org/10.1002/jps.1124)
  • 92. M. Ganzora, I. A. Khan. Planta Med. 67, 778 (2001).
  • 93. R. B. Anna, C. B. Maria, L. Diamanto, F. V. Franco. J. Agric. Food Chem. 50, 5016 (2002). (http://dx.doi.org/10.1021/jf020049j)
  • 94. G. M. Hanna. 11th Annual FDA Science Forum, Board Number: I-14, April 27 (2005).
  • 95. L. Wang, F. S. C. Lee, X. Wang. LWT-Food Sci. Technol. 40, 83 (2007).
  • 96. Romanian Pharmacopoeia X, Chap. IX, Ed, Medicala, Bucuresti (1993).
  • 97. British Pharmacopoeia, Vol. IV, Appendix XVI B, A356-A363 (2005).
  • 98. A. Ozbey, U. Uygun. Int. J. Food Sci. Technol. 42, 380 (2007). (http://dx.doi.org/10.1111/j.1365-2621.2006.01237.x)
  • 99. R. O. B. Wijesekera (Ed.). The Medicinal Plant Industry, CRC Press, Boca Raton (1991).
  • 100. V. Rai, P. Kakkar, C. Misra, S. K. Ojha, N. Srivastava, S. Mehrotra. Environ. Contam. Toxicol. 79, 269 (2007). (http://dx.doi.org/10.1007/s00128-007-9063-4)
  • 101. H. Wagner. In Handbook of Medicinal Plants, Z. Yaniv, U. E. Bachrach (Eds.), p. 3, Chap. 21, Haworth Medical Press, Binghamton (2001).
  • 102. V. G. Zuin, J. H. Yariwake, F. M. Lancas. J. Braz. Chem. Soc. 14, 304 (2003). (http://dx.doi.org/10.1590/S0103-50532003000200019)
  • 103. V. G. Zuin, A L. Lopes, J. H. Yarawake, F. Augusto. J. Chromatogr., A 1056, 21 (2004).
  • 104. S. Razic, A. Onjia, S. Dogo, L. Slavkovic, A. Popovic. Talanta 67, 233 (2005). (http://dx.doi.org/10.1016/j.talanta.2005.03.023)
  • 105. S. S. Razic, S. M. Dogo, L. J. Slavkovic. Microchem. J. 84, 93 (2006). (http://dx.doi.org/10.1016/j.microc.2006.05.008)
  • 106. S. Razic, S. Dogo, L. Slavkovic. J. Serb. Chem. Soc. 71, 1095 (2006). (http://dx.doi.org/10.2298/JSC0610095R)
  • 107. V. M. Dirsch, A. K. Kiemer, H. Wagner, A. M. Vollmar. Atherosclerosis 139, 333 (1998). (http://dx.doi.org/10.1016/S0021-9150(98)00094-X)
  • 108. V. M. Dirsch, A. L. Gerbes, A. M. Vollmar. Mol. Pharmacol. 53, 402 (1998).
  • 109. S. Klingelhofer. Isolierung und Charakterisierung antiinflammatorischer Oxylipine aus Blattextrakten von Urtica dioica L., Ph.D. Thesis, Kiel, Germany, Christian-Albrechts-Universitat, pp. 1-3 and 80 (2001).
  • 110. M. Kaszkin, K. F. Beck, E. Koch, C. Erdelmeier, S. Kusch, J. Pfeilschifter, D. Loew. Phytomedicine 11, 585 (2004). (http://dx.doi.org/10.1016/j.phymed.2004.02.003)
  • 111. W. E Mueller. St. John's Wort and its Active Principles in Depression and Anxiety, Birkhauser, Basel (2005).
  • 112. R. Verpoorte, Y. H. Choi, H. K. Kim. J. Ethnopharmacol. 100, 53 (2005). (http://dx.doi.org/10.1016/j.jep.2005.05.033)
  • 113. E. M. Williamson. Phytomedicine 8, 401 (2001). (http://dx.doi.org/10.1078/0944-7113-00060)
  • 114. API (Ayurvedic Pharmacopoeia of India). Department of Health, Ministry of Health and Family Welfare, Government of India, New Delhi, p. 45 (1989).
  • 115. P. P. H. But, T. Kimura, J.-X. Guo, C. K. Sung, B. H. Han (Eds.). International Collation of Traditional and Folk Medicine, p. 232, World Scientific, Singapore (1997).
  • 116. H. M. Chang, P. P. H. But (Eds.). Pharmacology and Applications of Chinese Materia Medica, Vols. I and II, S.-C. Yao, L.-L. Wang, S. C.-S. Yeung (Translators), World Scientific, Philadelphia (2001).
  • 117. V. K. Gupta. Traditional Knowledge Digital Library, Sub-Regional Experts Meeting in Asia on Intangible Cultural Heritage: Safeguarding and Inventory-Making Methodologies, Bangkok (2005). <http://www.accu.or.jp/ich/en/pdf/c2005subreg_ Ind1.pdf>.
  • 118. JSHM. Japanese Standards for Herbal Medicines, p. 361, Yakuji Nippo, Tokyo (1993).
  • 119. Jiangsu Institute of Modern Medicine. Zhong Yao Da Ci Dian (Encyclopedia of Chinese Materia Medica), Vols. 1-3, p. 3518, Shanghai Scientific and Technical Publications, Shanghai (1977).
  • 120. L. D. Kapoor. CRC Handbook of Ayurvedic Medicinal Plants, Herbal Reference Library, p. 416, CRC Press, Boca Raton (2001).
  • 121. K. M. Nadkarni. Indian Materia Medica, p. 414, Popular Prakashan, Bombay (1976).
  • 122. T. C. Lantz. Examining the Potential Role of Co-operatives in the Ethical Commercialisation of Medicinal Plants, Plant Conservation Intellectual Property Rights, Ethics, and the Devil's Club (Oplopanax Horridus). Occasional Papers 3, BC Institute for Co-operative Studies, University of Victoria, Victoria, B.C., Canada, 27 (2001).
  • 123. G. Tu (Ed.). Pharmacopoeia of the People's Republic of China (English ed., 1992), p. 202, Guangdong Science and Technology Press, Beijing (1992).
  • 124. United Nations. Convention on Biological Diversity, United Nations Treaty Series UN, New York, Vol. 1760, I-30619, 143 (1993).
  • 125. Online Archive of American Folk Medicine, University of California, Los Angeles. <http://www.folkmed.ucla.edu/>.
  • 126. Phytotherapies database. <http://www.phytotherapies.org/>.
  • 127. Natural Medicines Comprehensive Database. <http://www.naturaldatabase.com/>.
  • 128. HerbMed. <http://www.herbmed.org/HerbMed>.
  • 129. <http://www.cintcm.com/index.htm>.
  • 130. M. Van Dongen, E. Van Rossum, A. Kessels, H. Sielhorst. P. Knipschild. J. Clin. Epidem. 56, 367 (2003). (http://dx.doi.org/10.1016/S0895-4356(03)00003-9)
  • 131. AGRICOLA database, U.S. Department of Agriculture. <http://agricola.nal.usda.gov>.
  • 132. AltHealth Watch database. <http://www.epnet.com>.
  • 133. MANTIS database. <http://www.healthindex.com/>.
  • 134. MICROMEDEX database. <http://www.micromedex.com/products/altmeddex/>.
  • 135. Computer Retrieval of Information on Scientific Projects. <http://crisp.cit.nih.gov/>.
  • 136. Cochrane Collaboration. <http://www.cochrane.org/>.
  • 137. EMBASE, Elsevier. <http://www.embase.com/>.
  • 138. NAPRALERT, College of Pharmacy, University of Illinois at Chicago. <http://napralert.org/>.
  • 139. International Bibliographic Information on Dietary Supplements (IBIDS) database. <http://ods.od.nih.gov/Health_Information/IBIDS.aspx>.
  • 140. European Scientific Co-operative on Phytotherapy (ESCOP) database. <http://www.escop.com/phytonet.htm>.
  • 141. B. K. Vogler, M. H. Pittler, E. Ernst. Eur. J. Clin. Pharmacol. 55, 567 (1999). (http://dx.doi.org/10.1007/s002280050674)
  • 142. S. I. Hakky. U.S. Patent 4826684 (1989). <http://www.freepatentsonline.com/4826684.html>.
  • 143. S. Y. Lee. U.S. Patent 6692777 (2004). <http://www.patentstorm.us/patents/6692777.html>.
  • 144. R. Glaser. U.S. Patent 20070059384 (2007). <http://www.freepatentsonline.com/20070059384.html>.
  • 145. WHO. WHO Monographs of Selected Medicinal Plants, Vol. 1, p. 289, World Health Organization, Geneva, Switzerland (1999).
  • 146. WHO. WHO Monographs of Selected Medicinal Plants, Vol. 2, p. 351, World Health Organization, Geneva, Switzerland (2002).